Clinical Trial

Study of CM355 in Patients With Systemic Lupus Erythematosus

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 5, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
This study was designed to investigate the safety and efficacy of CM355 in patients with refractory SLE.
Trial Details
NCT Number NCT07104344
Lead Sponsor Second Xiangya Hospital of Central South University
Conditions Systemic Lupus Erythematosus
Enrollment 5 participants
Start Date 2025-09-25
Primary Completion 2026-04 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-08-05